Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells
about
Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptorsChemical methods for the simultaneous quantitation of metabolites and proteins from single cellsD1-type dopamine receptors inhibit growth cone motility in cultured retina neurons: evidence that neurotransmitters act as morphogenic growth regulators in the developing central nervous system.Cocaine exposure modulates dopamine and adenosine signaling in the fetal brain.Neurochemistry and behavior in man.Contrasting subcellular responses to monohydroxytamoxifen and oestradiol benzoate in the immature rat uterus [proceedings]Neurotransmitter receptors mediate cyclic GMP formation by involvement of arachidonic acid and lipoxygenaseRegulation of dopamine- and adenosine-dependent adenylate cyclase systems of chicken embryo retina cells in cultureInvolvement of calcium channels in short-term desensitization of muscarinic receptor-mediated cyclic GMP formation in mouse neuroblastoma cellsEvidence for involvement of cyclic nucleotides in intrinsic factor secretion by isolated rabbit gastric mucosa.Adenylate cyclase and acetylcholine release regulated by separate serotonin receptors of somatic cell hybrids.The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency.Epinephrine-induced elevation of guanosine 3':5'-cyclic monophosphate in isolated fat cells of rat.Voltage-sensitive calcium channels regulate guanosine 3',5'-cyclic monophosphate levels in neuroblastoma cellsImproved genetically-encoded, FlincG-type fluorescent biosensors for neural cGMP imaging.Cyclic GMP in a neuroblastoma clone: possible involvement in morphological differentiation induced by dibutyryl cyclic AMP.Regulation of synthesis of guanosine 3':5'-cyclic monophosphate in neuroblastoma cells.Effect of a phosphodiesterase inhibitor on cyclic GMP changes induced by muscarinic agonists in mouse neuroblastoma cells [proceedings]Hormonal aspects of the morphological differentiation of neuronal clonal cell lines.Muscarinic regulation of cAMP in mouse neuroblastoma.Regulation of cyclic nucleotide phosphodiesterases of cerebral cortex by Ca2+ and cyclic GMP.Effect of PGI2 and stable endoperoxide analogues on cyclic nucleotide levels in clonal cell lines of CNS origin.The ontogeny of dopamine-dependent increase of adenosine 3',5'-cyclic monophosphate in the chick retina.A method for measuring relative changes in guanosine 3':5'-cyclic monophosphate in mouse neuroblastoma cells on muscarinic cholinergic stimulation.Biochemical studies on muscarinic acetylcholine receptors.Muscarinic receptor-mediated dual regulation of ADP-ribosyl cyclase in NG108-15 neuronal cell membranes.Effect of some calcium antagonists on muscarinic receptor-mediated cyclic GMP formation.Design of fluorescence resonance energy transfer (FRET)-based cGMP indicators: a systematic approachLigand-binding propeties of the muscarinic acetylcholine receptor in mouse neuroblastoma cells.Effect of carbachol and 56 mm-potassium chloride on the cyclic AMP-mediated induction of tyrosine hydroxylase in neuroblastoma cells in culture.Stimulus-induced accumulation of inositol tetrakis-, pentakis-, and hexakisphosphates in N1E-115 neuroblastoma cells.Receptor-mediated increases in phosphatidylinositol turnover in neuron-like cell lines.Characterization of muscarinic receptors: type M2 (subtype B) on neuro-2A neuroblastoma cells.Guanine nucleotide regulation of agonist binding to muscarinic cholinergic receptors. Relation to efficacy of agonists for stimulation of phosphoinositide breakdown and Ca2+ mobilization.Prostaglandin induces Ca2+ influx and cyclic GMP formation in mouse neuroblastoma X rat glioma hybrid NG108-15 cells in culture.Regulation of muscarinic acetylcholine receptor concentration in cloned neuroblastoma cells.Thrombin effects on cultured nerve cells: clinical implications and evidence for a novel mechanism of neuronal activation.Expression of A1 adenosine receptors modulating dopamine-dependent cyclic AMP accumulation in the chick embryo retina.Calcium requirement for cGMP production during muscarinic activation of N1E-115 neuroblastoma cells.Cholinergic modulation of the Ca2+ response to bradykinin in neuroblastoma cells.
P2860
Q24298543-6A7FE597-59C8-44CF-A799-33969CCBB19CQ28833191-81C794ED-97C5-447D-AAB3-BCF151FCE6FBQ33568225-35C1721F-BF2E-4241-9999-26F51771C4D7Q33618429-EF63837B-3DAC-4EA1-863F-48D0EDA9EC4CQ34050493-34CCC9FE-78E2-497E-840B-AD20795987BAQ35177935-643CDD87-5868-49F7-A5B9-5E1DDB75D221Q36263635-1867B40D-8453-4972-82B9-80117A6FA6BFQ36312874-606CEF82-B432-4A5D-B684-2C22715D8CCEQ36416965-1125866B-3BB0-4C9C-AF40-BBA301C844DFQ37042590-70BEB535-EE91-4AA4-873A-B2C4C030C30BQ37319864-CF25223F-118B-4103-94E4-E01EA884A5EEQ37357752-6343DC01-938D-4C7F-A8B4-6FB5CB04D075Q37588142-CBCE67FD-CFAD-4EE3-871E-8B8BD554A752Q37597576-E6BD28F8-AD93-48AA-A8D1-D7525629CCD0Q39091633-7DD180C5-92CF-477E-80DE-8BD265FE7DABQ39156090-02DB3360-94BE-43CE-9B71-F5FB8250D567Q39225471-CD7782F7-2444-4FA9-B1D6-35BAA8C885E8Q39518842-5A1535F4-1B32-457E-B055-6967BCB32E3BQ39767095-8DE25771-7670-444B-A406-C08E065BFAF9Q40118798-DB5866C8-4108-47E9-AB6E-841A4B06B957Q40129857-2865FE3B-0F3A-406C-A5EE-969720818FCFQ40158943-C921BFF8-98CA-481D-AEC3-C12BA76AB1F5Q40179271-FE947C34-4375-41DE-A27D-87F71CDC1720Q40208231-8D16C731-DAD2-4266-83F4-A9ED1B174705Q40588008-A065C932-BBB3-4C67-88C2-B1DC704C70C4Q41066727-E1F24C2F-1C05-469F-BD41-0FB830B75498Q41555401-4D0912A8-117B-4CB6-8755-611AFF6F49ABQ41765778-53F87D2A-C24C-45FD-ACCD-A91E9F8CCF22Q41790380-246C01E0-0AA6-47A6-8EC9-17AA41C57D1CQ42445964-705C5D46-A9BC-4440-A792-D8FE120CC070Q42460341-D29F8DC9-3C20-40B6-9745-A97233EAA0E2Q42464199-C2225392-30B4-4788-94A7-6939BFC533BCQ42493542-2164A210-F1CA-4237-BD1C-CA4F0ECF5FB3Q42867178-262E0B3F-32C0-4CFE-BEAD-F625589C21E7Q43701694-05EB5116-3527-41B7-90A6-663BA4B1B725Q44600450-15187ABF-EAA6-4136-BA3C-1AC38A7C3CFFQ44702914-FA134D1C-BEBC-4FA0-B8FF-21520FB62B6DQ45057790-A5522FEE-449F-4476-8839-6B01EFED07C7Q45973021-78B6A964-3A44-40E8-849C-1569FD0AB550Q46014804-058C1E1F-8BE8-4E72-A7E9-88AF6B4CA96B
P2860
Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells
description
1975 nî lūn-bûn
@nan
1975 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells
@ast
Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells
@en
type
label
Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells
@ast
Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells
@en
prefLabel
Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells
@ast
Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells
@en
P2860
P356
P1476
Receptor-mediated shifts in cGMP and cAMP levels in neuroblastoma cells
@en
P2093
Matsuzawa H
Nirenberg M
P2860
P304
P356
10.1073/PNAS.72.9.3472
P407
P577
1975-09-01T00:00:00Z